-
HC Wainwright Reiterates "Sell" Rating for Sarepta Therapeutics (NASDAQ:SRPT)
Источник: Buzz FX / 16 янв 2025 09:55:16 America/New_York
HC Wainwright Reiterates "Sell" Rating for Sarepta Therapeutics (NASDAQ:SRPT) Written by MarketBeat January 16, 2025 Share Link copied to clipboard. HC Wainwright reaffirmed their sell rating on shares of Sarepta Therapeutics ( NASDAQ:SRPT
Read more...